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Diagnosing post-traumatic stress disorder (PTSD) is challenging and is currently, 
diagnosis through self-administered checklists. Because a diagnosis of PTSD can 
open up significant benefits to compensation, education, and medical care, 
people can tailor their responses to the checklist to help ensure a diagnosis of 
PTSD. The purpose of the study was to examine the utility of the quantitative 
electroencephalograph for diagnosing PTSD. Frequency and presence of 
biomarkers and alpha brain wave symmetry in the frontal and parietal lobes were 
examined. Research questions involved examining the presence of alpha wave 
imbalance across the frontal lobe and between the right and left parietal lobes. A 
secondary data analysis was conducted using data from 108 subjects; these data 
included records from those with and without a PTSD diagnosis. The results of 
logistic regression showed that 63% of the clients diagnosed with PTSD were 
correctly identified and between 7% and 8% of the variance in PTSD was 
accounted for by frontal lobe asymmetry. The parietal lobe imbalance correctly 
classified PTSD in 59% of the patients and it identified 3.5–4.9% of the variance, 
suggesting that asymmetry in the frontal and parietal lobes should not be used as 
the primary method for diagnosing PTSD. Implications for social change include 
identifying an objective diagnostic tool that can potentially decrease the 
possibility of inaccurate diagnoses based on self-reported symptoms. This could 
lead to eliminating some of the shame and embarrassment veterans and first 
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Chapter 1. Introduction to the Study 
Introduction 
 Posttraumatic stress disorder (PTSD) has long been recognized as a mental 
disorder related to exposure to traumatic events such as assault, warfare, and other 
threats on a person's life (Ntafoulis, 2016). Historians, such as Ntafoulis, have traced 
post-battle-related psychiatric symptoms as far back as ancient Greece and the middle 
Byzantine period. Over 2,000 years ago, Greek warriors would return from battle with 
symptoms that could not be explained by Hippocratic physicians (Ustinova & Cardeña, 
2014). In the twenty-first century, PTSD remains a leading consequence of modern-day 
war. Today it is considered to be a signature injury, affecting approximately 1 in 12 
veterans who served in Iraq or Afghanistan (Patel, 2015).  
  Ustinova and Cardeña (2014) noted that ancient historical methods used to care 
for damaged warriors, such as ritual cleansing and penance, would help ease the 
traumatic ruptures of self, time, and cognition. But they were short-term solutions. 
Because war-related trauma was considered a condition that medical providers of the 
time could not cure, long-term treatments were neither offered (Ustinova & Cardeña, 
2014). Therapies currently used include trauma-focused psychotherapies and 
antidepressant medications.  
  Building on this history has shown mental health practitioners that PTSD and 
depression are often co-occurring. Researchers have long recognized that PTSD and 
major depressive disorder (MDD) can be linked in some manner (Kostaras, 





that comorbidity rates between PTSD and MDD can be as high as 36%. Each of these 
disorders could require different mental health treatment options. Difficulties 
differentiating between the two disorders carry significant implications (Kostaras et al., 
2017).  
These are not the only disorders that may need differentiation. PTSD can also be 
differentiated from other trauma- and stressor-related disorders in which exposure to a 
traumatic or stressful event is listed explicitly as a diagnostic criterion, such as reactive 
attachment disorder, disinhibited social engagement disorder, acute stress 
disorder, adjustment disorders, anxiety disorders, obsessive-compulsive disorder, and 
dissociative disorders. Differentiating among possible trauma-related disorders can be a 
crucial aspect of providing the most effective treatment (Blake, Lating, Sherman, & 
Kirkhart, 2014).  
 Military personnel, police officers, firefighters, emergency medical technicians, 
and other first responders are among those exposed to traumatic events in the course of 
their duties. Diagnosis and differentiation of PTSD from other disorders is typically 
accomplished through self-report assessments (You, Youngstrom, Feeny, Youngstrom, 
& Findling, 2017).  Tsai et al. (2016) reported that self-assessments lack validity and 
authenticity. Furthermore, the symptoms of PTSD can be coached and rehearsed before 
a person visits a mental health therapist (Potik, Feldinger, & Schreiber, 2012). 
Coaching and rehearsal can potentially be detected through malingering 
measures on assessments. Malingering—the exaggeration and/or feigning of symptoms 





medications, compensation, and benefits. . Bryant et al. (2018) suggested that self-
report instruments are particularly susceptible to malingering behaviors. In their study, 
they found that the students in the malingering group had much higher malingering 
scores than nonmalingering students. This suggests that the malingering students 
recognized the answers that could be key to a diagnosis of a mental health disorder.  
However, assessment instruments can also vary greatly when evaluated for 
potential accuracy related to detection and differentiation of disorders. You et al. (2017) 
found that students reported symptoms more accurately than teachers reported the 
observed behaviors of the children. Assessments were found to rely on subjective 
measures that vary from person to person. Therefore, their accuracy and reliability 
continue to be a challenge. Researchers and clinicians (Vermetten, Baker, Jetly & 
McFarlane, 2016)., and authors of the Diagnostic and Statistical Manual of Mental 
Disorders (5th ed., American Psychiatric Association, DSM-5) continue to debate about 
under-diagnosing and overdiagnosing PTSD and other trauma-related disorders.  
Background 
Jokić-Begić and Begić (2003) conducted research on to the utility of qEEG for 
diagnosing mental disorders. This small pilot study used qEEG to compare qEEG in 
combat veterans with and without PTSD. Their study was able to confirm differences 
among qEEG characteristics between the combat veterans with PTSD and the control 
group of veterans without PTSD. The results demonstrated that veterans with PTSD had 





PTSD. The authors offered various explanations for decreased alpha activity and 
increased beta rhythm activity in those veterans with PTSD (Jokić-Begić & Begić, 2003).  
Findings reported by a 2012 study conducted by Jaworska et al. (2012), were 
consistent with previous studies regarding alpha power, alpha wave activity, and 
asymmetry or imbalance. Unlike self-assessments, a technological instrument such as a 
qEEG can provide a standard measure of brain wave asymmetrical patterns in the 
frontal brains of individuals with depression or PTSD (Kemp et al., 2010). In a 
systematic review of 1178 EEG references, Lobo et al. (2015) found that qEEG held 
considerable ability as an evaluation tool for detecting these biomarkers. However, they 
concluded that further study on this evaluation tool was required. Power asymmetry, 
based on absolute frontal and parietal alpha, might provide another PTSD biomarker.  
Prior research supports the efficacy of biomarkers as potential identifiers of 
specific mental disorders (Moss, Cannon, Thatcher, Koberda, & Gunkelman, 2014). 
Moss et al. explained that biomarkers have been approved by the Food and Drug 
Administration (FDA) to support or rule out a diagnosis of attention deficit and 
hyperactivity disorder. Identification of additional biomarkers through the use of qEEG 
brain scans are being studied as evidence-based sources for diagnosing mental disorders 
such as PTSD. 
Problem Statement   
  An evidenced-based tool such as the qEEG can analyze brain function and more 
accurately detect biomarkers that would indicate the presence of PTSD (Rivers, 2013). 





second, alpha brain wave asymmetry in the frontal lobe, can be potential biomarkers of 
PTSD (Lobo et al., 2015; Kemp et al., 2010). A common challenge related to diagnosing 
PTSD is the training associated with administering assessments that can identify PTSD 
symptoms (Brewin et al., 2017. It is anticipated that the International Statistical 
Classification of Diseases and Related Health Problems 11(ICD-11) will change criteria 
for PTSD, further supporting the need for an evidenced-based diagnostic tool able to 
diagnose PTSD and complex (repeated) PTSD (Brewin et al., 2017). 
According to Frueh (2013), malingering associated with disorders such as PTSD 
can be difficult to detect. Veterans, police officers, and other first responders can reap 
financial benefits from a diagnosis of PTSD. A psychometrist or therapist may 
misunderstand or misdiagnose the observed behaviors believed to reflect PTSD 
(Yamaguchi et al., 2016). These behaviors might be observed by the clinician or 
experienced as symptoms by the patient. However, as highlighted by Yamaguchi et al. 
(2016), these symptoms and behaviors are subjective measures and can be misidentified 
or misinterpreted by both parties. In the case of a child, the parents and teachers might 
also inadvertently misread potential symptoms and behaviors. An objective diagnostic 
tool such as the qEEG would decrease the possibility of inaccurate diagnoses based on a 
patient’s self-reported symptoms. The intent of this dissertation was to examine the 
frequency of biomarkers identified by qEEG in adults diagnosed with PTSD. 
This problem statement addressed the indicators observed in the brain scans of 
individuals with PTSD. A database of brain scans showing patterns that have been 





process of diagnosing PTSD. Recording and analyzing PTSD biomarkers would provide 
evidence-based approaches to diagnosing adults and children who have experienced 
traumatic events. In other words, identifying biomarkers will remove some of the 
subjectivity associated with the current self-report assessments.  
Purpose of the Study 
 The purpose of this study was to identify biomarkers related to PTSD using 
qEEG. Biomarkers were qualified and quantified through direct observation of qEEG 
readings of brain activity. Current diagnostic methods only assess symptoms based on 
self-report instruments (Tsai et al., 2016). The use of qEEG to identify abnormal brain 
activity can be expected to provide a more accurate assessment by identifying specific 
brain wave activity and the presence of PTSD. Specifically, the presence of two potential 
biomarkers were sought: increased global alpha activity in the right parietal lobe and 
alpha asymmetry in the frontal lobe (Lobo et al., 2015; Kemp et al., 2010).  
  Kemp et al. (2010) found that alpha wave asymmetry across the frontal lobe is 
potentially unique to people with PTSD. A preliminary study by Wahbeh and Oken 
(2013) identified an increase in global alpha power in the right parietal region of the 
brain when compared to the left parietal region. The intention of this study was to 
provide an analysis that contributes to closing the gap in understanding the use of qEEG 
to identify abnormal brain activity and confirm a diagnosis of PTSD (Lobo et al., 2015; 






  Earlier research has shown that alpha brain wave asymmetries across the frontal 
lobe (biomarker B1) and increased alpha brain waves in the right parietal lobe 
(biomarker B2) can potentially indicate the presence of PTSD. In this study, 
combinations of the two biomarkers as an effective form of PTSD diagnosis were 
examined. Alpha waves in the frontal lobe can range from 8–12 cycles per second. 
Elevated alpha in the left frontal lobe must be considered in comparison to the right 
frontal lobe. Both measurements could be in the normal range of 8–12 cycles per second 
and still be imbalanced.  
   Alpha brain wave activity of 12 cycles per second in the left frontal lobe would 
not be significant. However, an alpha of 12 cycles per second in the left frontal lobe and 
8 cycles per second in the right frontal lobe would be significant, even though they are 
both within normal ranges. This situation can also be present when considering the 
parietal lobe. The alpha cycles per second being the same as the frontal lobes for this 
area was considered. Additionally, there might also be an interaction between the 
variables, independent of their effect on the brain. Analysis of the frontal and parietal 
lobes can? highlight any potential interactions between the lobes. The tool will 
potentially determine if the imbalance in the parietal lobe is also creating an imbalance 
in the frontal lobe or vice versa. Thus, the research questions were as follows: 
    
1. Does a sample of tested adults diagnosed with PTSD have detectible alpha brain 





2. Does a sample of tested adults diagnosed with PTSD have detectible alpha brain 
wave asymmetries across the parietal lobe? 
Hypotheses 
H01: Adults diagnosed with PTSD do not have detectible alpha wave asymmetries 
across the frontal lobe (Biomarker 1) compared to adults who have not been diagnosed 
with PTSD.  
 (Ha1): Adults diagnosed with PTSD have detectible alpha wave asymmetries 
across the frontal lobe (Biomarker 1) compared to adults not diagnosed with PTSD.  
 (Ho2): Adults diagnosed with PTSD do not have detectible alpha wave 
asymmetries across the parietal lobes (Biomarker 2) compared to adults that have not 
been diagnosed with PTSD.  
   (Ha2): Adults diagnosed with PTSD have detectible alpha wave asymmetries 
across the parietal lobes (Biomarker 2) compared to adults that have not been diagnosed 
with PTSD.  
Nature of the Study 
 A quantitative non-equivalent control group quasi-experimental research design 
using archival records was used to examine the utility of qEEG scans for the diagnosis of 
PTSD. The study was anonymous; all patient files were extracted without identifying 
information. To ensure anonymity, prior to each patient’s inclusion study, a random 
number was assigned. This random number was used as the primary identifier of the 
information related to a specific client. The random number was given to the researcher. 





gathered the data. The number was used in case there was issue with the patient file. To 
resolve such issues, the researcher reported potential issues to the practice manager and 
the manager resolved issues and provided the resolution if there was one, without 
identifying the patient to the researcher. The sample of brain scans was examined and 
compared for the presence of both biomarkers. A binary logistic regression was used to 
measure whether frequencies of detectible biomarkers were significantly different 
between the two groups of patients. The use of this data was approved by Walden 
University Institutional Review Board.  
Theoretical Framework 
 The framework of this study centered on current concepts related to trauma and 
the diagnosis of mental trauma and trauma-related disorders such as PTSD. Carlson 
and Dalenberg (2000) provided a theoretical framework to address symptoms and 
organic changes to a person’s brain produced by traumatic experiences. This framework 
supports the theory that PTSD causes psychological and organic changes in a person’s 
brain. These changes can result in potentially disabling symptoms. These symptoms 
will, most likely, not be reduced or eliminated until they have been addressed through 
psychotherapy, psychopharmacological interventions, or both. 
 The DSM-5 provides specific symptomology and behaviors that can be identified 
in order to diagnose disorders such as PTSD (DSM-5, 2013). However, some of these 
symptoms and behaviors can be associated with other disorders. Recognizing potential 
organic changes to a brain as an identifier and unbiased specifier is a benefit of the 





that highlights interrelationships between brain function and trauma-related brain 
modifications.  
 People undergo potential traumas throughout a lifetime of development. Kira, 
Lewandowski, Chiodo, and Ibrahim (2014) offered a theoretical framework that 
supports traumatic experiences and its impact on a developing brain. Effects such as 
modified brain waves on a developing brain can produce symptoms that are potentially 
associated with changes in specific areas of the brain. These changes might be the source 
of identifiable symptomology and behaviors as a person progresses through the stages of 
brain development. An example might be a child that experiences a traumatic event that 
results in hypervigilance. This hypervigilance could be seen on a brain scan and become 
a biomarker for PTSD. The Kira et al. (2014) framework supports the portion of the 
study in regard to development and traumatic events (Kira, Lewandowski, Chiodo, & 
Ibrahim, 2014).  
 The study used a quasi-experimental quantitative experimental approach to 
determine potential relationships between variables. A quantitative study compares 
variables as a way to reveal potential relationships. The study framework was more 
conceptual, based on available data and the hypothesis (Creswell, 2014).  
Definition of Terms 
Alpha waves: Alpha waves represent brain wave activity that oscillates in the 8 – 
12 cycles per second frequency range (Gerrard & Malcolm, 2007). This is the first brain 
wave activity discovered by Hans Berger, the inventor of electroencephalography (EEG). 





Biological marker: A biological marker (biomarker) is an identified indicator of a 
state or condition (Strimbu & Tavel, 2010). In this document, a biomarker is a potential 
identifiable brain condition that can be assessed and measured. Biomarkers were first 
identified in the 1950’s in regard to biological conditions. Brain biomarkers became a 
focus in the 1970’s and 1980’s. 
Brain wave activity: This is neural activity that occurs in the central nervous 
system (Gerrard & Malcolm, 2007). This electrical activity is rhythmic or repetitive and 
can be detected on an EEG. Alpha waves are of particular interest in this paper. 
Frontal lobe and prefrontal cortex: These are parts of the brain located in front 
of the temporal and partial lobes in the mammalian brain (Miller, Freedman & Wallis, 
2002). The prefrontal cortex covers the front of the frontal lobe and is responsible for 
functions associated with executive decision making and memory. Most importantly, 
this portion of the brain assigns emotions to anxiety related activity generated by the 
limbic system.  
Hypervigilance: The DSM-5 defines hypervigilance as “An enhanced state of 
sensory sensitivity accompanied by an exaggerated intensity of behaviors whose purpose 
is to detect threats” (p.823) (APA, 2013). This enhanced state results in a person 
constantly scanning for threats and can lead to exhaustion. Hypervigilance can engage 
all of a person’s senses. 
 Major depressive disorder (MDD): MDD is defined in the DSM-5 as a period of 





weeks (APA, 2013). MDD can also be associated with PTSD and PTSD related 
symptomology. 
 Parietal lobe: The parietal lobe is an area of the brain responsible for somatic 
responses, such a s touch and temperature, spatial awareness, attention, and visual 
motion (Smith, 2007). Of importance is the cognitive processing of sensory information. 
 Posttraumatic stress disorder (PTSD): PTSD is a mental disorder characterized 
by symptoms following exposure to trauma events (APA, 2013). Some of the symptoms 
include fears related to re-experiencing the event with emotional and behavioral 
reactions.  
Quantitative EEG (qEEG): qEEG is a method of mapping and analyzing 
brainwaves using electroencephalography (Chabot & Serfontein, 1996). Leads are 
placed on the scalp of a person and electrical activity is detected and measured. The 
results are then compared to a database of brains in order to identify potential 
biomarkers for specific mental disorders. 
 Temporal lobe: These lobes of the brain are responsible for long term memory 
associated with the hippocampus (Smith, 2007). This area is also responsible for brain 
functions associated with emotional processing, language comprehension, and visual 
memory. 
Assumptions, Scope and Delimitations, Limitations 
Assumptions 
 The narrative databases are the result of qEEG brain scans of adults considered 





and identify subjects that fall into the normal range of functioning. Scans of adults with 
only one mental health diagnosis were used. This study assumes that patients did not 
have a co-occurring mental health disorder. Databases correctly produced and recorded 
biomarkers that were analyzed and compared.  
Scope and Delimitations 
The databases of qEEG assessments conducted for this study were the primary 
source of brain scans. This helped ensure that the scans had been properly analyzed. 
Additionally, every brain scan in the database had undergone the same level of 
assessment. Each patient’s qEEG was conducted with the same procedures and every 
patient was administered the same panel of traditional assessments with certified 
psychometrists or licensed mental health practitioners who had diagnosing as part of 
their scope of practice. . The delimitation associated with this study was that the brain 
scans used were limited to those already gathered and input into a database. This 
decision was made in order to help eliminate patients who were still in the diagnosing 
process. 
Limitations. Todder, Levine, Abujumah, Mater, Cohen, & Kaplan (2012) 
support the identification of biomarkers in specific areas of the brain. These biomarkers 
could then be used to support a diagnosis of PTSD using qEEG. The sample size (N= 20) 
was small, but it could still provide an understanding of the potential functionality of 
biomarkers. The sample size of this case-comparison study was also small (N = 20) but 
was anticipated that evidence-based information of critical neurological importance 





Significance of the Study 
 The relationship between certain brain-function biomarkers and PTSD symptoms 
needs to be better understood. An increased awareness of this link can potentially 
improve diagnosis and targeting of therapeutic options. This study explored the 
presence of alpha asymmetries in the frontal lobe and alpha power imbalances between 
the right and left parietal lobes as potential biomarkers in identifying PTSD. Research 
on this gap in understanding may support the justification of using qEEG as a primary 
diagnostic tool for PTSD.  
Implications for Positive Social Change 
These findings could result in positive social change by providing an evidence-
based process to support the diagnoses of PTSD. This social change might help 
eliminate some of the shame and embarrassment veterans feel toward seeking help for 
PTSD. Typically, veterans avoid potential diagnosis and treatment because the warrior 
culture frowns upon mental health issues as signs of weakness. Price (n.d.) indicated 
that the perceptions of the public toward law enforcement officers with PTSD can also 
be an area of positive social change. The author stressed that current public and 
governmental perceptions of job-related stressors for law enforcement are not readily 
supported by evidenced based diagnosing. Difficulties related to diagnosis and 
treatment can result (Price, n.d.). Changing these perceptions can improve care and 








 Chapter 1 introduces the quantitative electroencephalogram as a tool used to 
identify potential biomarkers in a patient’s brain. These biomarkers can be used as a 
way to provide an evidenced based diagnosis of trauma based mental disorders. Also 
presented were the problem statement, purpose, research questions, and hypothesis 
related to the study. Additionally, definitions of unique terms were addressed, as well as 
delimitations, the scope of the study, and potential limitations. Finally, the significance 
of the study and possible positive social changes were addressed. 
 Chapter 2 presents a review of the literature on qEEG and brain biomarkers. It 
also highlights strategies on changes in brain speed and power in different parts of the 
brain. Specifically, potential organic changes to the brain of a person with PTSD and 
other trauma-related mental disorders are explored. The gap on the identification of 
biomarkers in the frontal and parietal lobes is also explored. Chapter 2 includes ongoing 
studies related to brain biomarkers and brain wave activity. The theories introduced in 
Chapter 1 are presented and further supported. 
 Chapter 3 is the area in which methods and procedures are described. The 
selection of subjects and the collection of data is outlined. This study uses data that had 
already been collected; no participants were recruited. Justification for the number of 
subjects and the selection criteria regarding digital records are explained. 
 Chapter 4 reports the results of the data analysis. The data set includes a range of 





disorders. Biomarkers from other disorders provided a level of consistency. This chapter 
contains narrative statements related to the presentation of the findings for this study. 
 Chapter 5 offers the interpretation of the study as related to the necessity of the 
identification of biomarkers related to PTSD and other trauma-related mental disorders. 
This is also the area that addressed positive social change regarding veterans’ 
perceptions regarding mental health care. Recommendations for use of these findings 





Chapter 2: Literature Review 
Introduction 
 The diagnosis of PTSD is problematic for states, cities, police departments, 
private companies and governments, to name a few. This includes, for example, the 
struggles faced by the Department of Veterans Affairs regarding the diagnosing of PTSD 
for compensation and benefits claims, as well as lower level governmental agencies and 
private companies with workers who many experience traumas. People with PTSD 
symptoms are sometimes misdiagnosed and end up being incorrectly treated and/or 
attempting to self-medicate. Because a diagnosis of PTSD can open up significant 
benefits related to compensation, education, and medical care, there is the problem of 
secondary-gain and malingering, or accusations of malingering by potential PTSD 
patients. Using a tool that analyzes brain wave activity is one way in which subjective 
factors can be removed from the process. 
 A 2011 study conducted by Jackson et al. (2011) revealed that mental health 
professionals, primarily psychologists, did not typically use assessment instruments to 
diagnose PTSD. This study indicated that 53% of the clinicians receiving and returning 
surveys preferred to use an interview over evidenced-based assessment instruments, 
such as the Clinician Administered PTSD Scale (CAPS). Of the respondents, 59% never 
used assessment instruments in the diagnosing process. This overreliance on a 
subjective interviews and perceived expert opinion could allow for increased 
malingering and secondary gain. Jackson et al. (2011) highlighted the increase in 





indicated that secondary-gain incentives might lead some veterans to malinger as a way 
to receive or increase compensation through the Veterans Administration (VA) Benefits 
office. 
 As an example of the quandary created by subjective assessments, McNally and 
Frueh (2012) argued that the Jackson et al. (2011) study minimizes the problems 
related to secondary-gain and malingering in the administration of veterans’ benefits 
related to PTSD. McNally and Frueh`) highlighted a VA Inspector General report, which 
indicated that only 21% of veterans receiving at least 50% compensation for PTSD had 
an identifiable traumatic incident in their service history. Exacerbating the potential for 
malingering is the expansion of PTSD symptoms to include people who experience a 
fear of hostile military and/or terrorist activity. The report revealed that a vast majority 
of veterans would cease PTSD mental health treatments when compensation ratings 
would reach 100%. These types of conflicting reports and studies reinforce the need for 
an objective assessment process, much like that of an X-ray revealing a broken bone. 
 Marx et al. (2012) responded to the Jackson et al. (2011) study and the McNally 
and Frueh (2012) rebuttal reply. Marx and colleagues came to the defense of veterans, 
VA clinicians, and the assessment process related to PTSD. Their response highlights 
potential inaccuracies in/of what exactly? related to the reasons for delayed PTSD 
assessments for Vietnam era veterans. These potential inaccuracies include insufficient 
sample size and generalization of results across the entire veteran population. The 
authors also indicate that steep increases in the number of veterans applying for PTSD 





can possibly be attributed to better education and other factors compelling people to 
seek treatment and compensation other than secondary gain and malingering. 
 However, it is important to emphasize that the Veteran’s Administration is not 
the only organization struggling with the diagnosing of PTSD. Workman’s 
compensation, social security, civil lawsuits, and other civilian agencies and 
organizations also experience these challenges (Matusko, Kemp, Paterson & Bryant, 
n.d.). Matusko et al. (n.d.) highlight that few psychological assessors will screen for 
malingering. However, psychiatrists appear to be the exception. Analysis of the data 
produced by psychiatrist in Australia indicates that over 50% of the people assessed for 
PTSD triggered indexes related to malingering. 
The following review of the literature offers that the diagnosis of PTSD presents 
challenges for clinicians and patients. Currently, the diagnosing process is based on 
diagnostic interviews and self-report instruments that rely on patient disclosures and 
clinician observable symptoms (Jackson et al., 2011). The identification of biomarkers 
related to brain activity that can be detected through a qEEG analysis could present a 
more effective diagnostic process and tool.  
Literature Search Strategy 
 The literature search strategy focused on the problem, things that need further 
understanding and then on potential solutions. This is an emerging area of psychology. 
Applying brain function and physiology to potential mental disorders needs to be 





that focuses on development of specific ideas was an important starting point for this 
paper. 
The following electronic databases—a, b, c, d—were searched using the following 
key words: quantitative electroencephalography (), brain waves, biomarkers, brain 
power, alpha waves, posttraumatic stress disorder, and PTSD. I used a chronological 
focus for each portion of the literature review. The intent was to show the original 
research, where it has progressed to, and then additional areas of study, followed by the 
gaps I am addressing. One important question was to identify how qEEG been used in 
the past to help diagnose mental disorders.  
 The problem remains of finding an objective assessment process for veterans in 
regard to PTSD claims to the Veterans Benefits Administration (VBA), a division of the 
VA, social security, and other agencies struggling to properly support people. This part 
of the literature review focused on searches related to the number of veterans seeking 
compensation and the assessment methods used in the diagnosing process. Key words 
included in this part of the literature review included PTSD assessment instruments, 
PTSD claims, diagnosing PTSD, secondary gain malingering. The results were then 
narrowed down using search terms related to veterans by era, combat service, traumatic 
events, and VA assessment process. These results were then presented in a 
chronological manner. This was one way in which the research could be outlined in a 
way that reflects the manner in which the research has been conducted and hope it has 





 These searches revealed findings that need further understanding, such as how 
certain brain powers and speeds can be identified using technology such as qEEG. 
However, the interactions between different areas of the brain is still an area of research 
and understanding. An example could be used that an imbalance in a certain brain wave 
activity across the parietal lobes might also cause an imbalance in other areas of the 
brain. For this reason, it is important to include interactions across lobes of the brain 
and then also evaluate potential interactions between different lobes of the brain. Search 
terms regarding brain asymmetry, brain power, brain speed, and frontal/parietal lobe 
imbalance were used in support of this area of the literature review.  
Potential solutions regarding objective assessment instruments were then 
searched as part of the literature search strategy. Other disorders, such as attention 
deficit hyperactivity disorder (ADHD) and depression, were used as part of the search 
terms for this area. Some of these areas have been extensively researched and can 
provide some valuable insights and support for this study. ADHD in particular has been 
an area that has been researched and analyzed for many years. The Food and Drug 
administration approved qEEG as a supportive tool that can be used in conjunction with 
traditional assessments in the diagnosis of ADHD (Rivers, 2013). 
 This comprehensive literature review reflects the current and past state of qEEG 
research. This research is then applied in a manner that supports the use of this 
technology in the diagnosis of mental health disorders. On the other hand, this 
information can also potentially support the absence of a suspected mental health 






The DSM-5 provides specific symptomology and behaviors that can be identified 
in order to diagnose disorders such as PTSD (APA, 2013). However, some of these 
symptoms and behaviors can also be associated with other disorders. Recognizing 
potential organic changes to a brain as an identifier and unbiased specifier is a benefit of 
the Carlson and Dalenberg (2000) framework. Additionally, this theoretical framework 
is one of the few that highlights interrelationships between brain function and trauma 
related brain modifications.  
Addressing and identifying symptoms and linking them to organic changes to a 
person’s brain produced by traumatic experiences is one alternative to traditional 
neuropsychological assessment. This framework supports the theory that PTSD causes 
psychological and organic changes in a person’s brain. These changes can result in 
potentially disabling symptoms. These symptoms will, most likely, not be reduced 
and/or eliminated until they have been addressed through psychotherapy, 
psychopharmacological interventions, or both. 
The manner in which veterans are maligned by the Department of Veterans 
Administration and the manipulation of the system by some veterans can be 
disheartening (Jackson et al, 2011). Research indicates that between 40 and 60% of 
veterans will be diagnosed with PTSD (Tsai et al., 2016). This represents a significant 
number of people being diagnosed using traditional assessment instruments. The 
presence of only one of the four potential biomarkers associated with PTSD could be an 





disorder. This type of detectable organic brain change could be the basis for a person 
being granted care, denied care and provided or declined compensation.  
On the other hand, people could be exaggerating or presenting false symptoms as 
a way to manipulate the disability and determination system (Jackson et al, 2011). This 
type of malingering can be prevented through the use of an objective assessment 
instrument that can gather and analyze brain wave activity. More importantly, veterans 
and other people seeking care and/or compensation, would be able to use this objective 
system as a support for initial claims and future appeals. The authors highlight that 
approximately 9% of the greater population can be expected to develop PTSD after a 
traumatic event. This is far lower than the PTSD rates detected by the VA using 
traditional psychological assessment instruments. It is even lower than the number of 
people in the general population that typically develop PTSD following a traumatic 
experience. However, these numbers can be skewed based on the trauma and other 
factors. An example is survivors of rape and sexual assault. Mboqi-Mbalo, Zhang, and 
Ntuli (2017) found in a study analyzing statistics related to women and sexual assault 
found that 53% of the subjects reported symptoms associated with PTSD and 
depression. 
 Carlson and Dalenberg (2000) provide the theoretical foundation for this 
dissertation. The authors have developed this theory based on previous research 
supporting the effects of traumatic experiences on a person. Factors related to a trauma 
can result in cognitive, affective, behavioral, and physiological changes in a person. 





the impact of the trauma on the person brain form and function. In other words, 
traumatic events can result in observable changes to a person’s brain.  
A qEEG can detect these types of changes to the brain and produce identifiable 
biomarkers. Carlson and Dalenberg (2000) further explain that these identifiable 
changes can potentially be the source of (or the effects of) depression, aggression, and 
behavioral changes, just to name a few. The area of the brain affected can possibly 
indicate the level of dysfunction related to PTSD and other trauma related disorders. 
For instance, depression can be identified by qEEG through the detection of an 
imbalance (asymmetry) between the brain wave activity in the right and left frontal 
lobes of the brain. This asymmetry would be a potential biomarker that could be 
detected and combined with other biomarkers to diagnose PTSD based on an observable 
change to a person’s brain function. 
 The traumatic framework identified by Carlson and Dalenberg (2000) is based on 
a fight or flight or freeze limbic system response. The model recognizes that these 
responses can then be reignited (triggered) at a later time in which a similar threat is 
encountered by the victim. The rush of adrenaline, dopamine, and other chemicals in 
the body through activation of the sympathetic nervous system is one potential source of 
organic changes in the brain. The persistent nature of the symptoms points toward a 
change of state within the brain and body of a traumatized person. The authors use the 
example of a person that disassociates during a traumatic event as an indicator of a 
change to the basic function of the persons brain. When triggered by a later situation 





 People undergo potential traumas throughout a lifetime of development. Kira, 
Lewandowski, Chiodo, and Ibrahim (2014) offer a theoretical framework that supports 
traumatic experiences and the impact on a developing brain as outlined by Carlson and 
Dalenberg (2000). This effect can produce symptoms potentially associated with 
changes in specific areas of the brain. These changes might be the source of identifiable 
symptomology and behaviors as a person progressed through the stages of development. 
An example might be a child who experiences a traumatic event that results in 
hypervigilance. This hypervigilance could be viewed on a brain scan and become a 
biomarker for PTSD. The Kira et al. (2014) framework supports the portion of the study 
in regard to development and traumatic events. 
A Review of the Literature 
Combat stress related disorders are among the most consistent and documented 
psychiatric conditions throughout history (Ustinova & Cardeña, 2014). The ancient 
Greeks would notice changes in warriors they sent off to defend their country and 
invade others. However, the physicians from ancient Greek times typically would 
document the changes but would not treat the potential disorders that they could not 
explain.  
Ustinova and Cardeña (2014) explained that three factors should be present in 
order for a brain to be considered traumatized. The first is a biological predisposition 
related to susceptibility of a person to have a linger trauma response. The second is 
coping strategies that can build resiliency as a potentially prophylactic effect to protect a 





traumatized person. The area of interest from Ustinova and Cardeña (2014) is the 
potential genetic predisposition of a person to be vulnerable to lingering emotional 
responses after a traumatic event. The lingering organic changes to a person’s brain 
might not have been detectable in history. However, modern technologies have 
progressed to the point in which brain form and function can be evaluated through the 
use of objective brain assessment instruments such as a qEEG. Subjective instruments, 
while well supported for validity and reliability, still have affects that can be misread or 
manipulated by a patient or assessor. A process that is based on objective instruments 
can help minimize or eliminate subjective factors associated with the current PTSD 
evaluation process. 
Self-report assessment instruments are the most common method of diagnosing 
PTSD. However, these types of instruments, while well-supported, can be influenced by 
the person being assessed and potential biases of the assessor. Tsai, Pietrzak, Hoff, and 
Harpaz-Rotem (2016) highlighted the importance of developing a way to diagnose 
PTSD outside of the current self-report instruments. Tsai et al., (2016) found that 
differences in the criteria of a self-report instrument resulted in a greater than 20% 
difference in the number of people diagnosed with PTSD. For instance, veterans 
assessed using one criterion resulted in 40% of the population being diagnosed with 
PTSD. However, using the clinician documented criteria resulted in 62-84.5% of the 
population screening positive for PTSD.  
The Tsai et al. (2016) numbers show a drastic increase over the 9% rate of PTSD 





Dalenberg (2000). One possible reason for the increase cited by Tsai et al. (2016) is that 
VA clinicians were aware of the assessment results and still relied on clinical skills to 
reach a diagnosis. QEEG biomarkers related to PTSD could be utilized to support or 
rule-out a PTSD diagnosis. Overall, the data from this study was applied to the veteran 
population. However, there is potential for further research to open it up to all people 
that have experienced PTSD symptoms.  
A process to diagnose PTSD that cannot be controlled or affected by the assessor 
or patient would help increase reliability and validity of the PTSD screening process. 
Falconer et al. (2008) focuses on autonomic functions in the brain that are affected by 
PTSD. This study indicated that left cortical responses in people with PTSD were 
detectible biomarkers. This potential activation imbalance could help provide data that 
can be analyzed and evaluated outside of typical self-report instruments used for current 
diagnosing. The finding of increased left cortical activity and decreased right cortical 
activity might be a potential biomarker of PTSD. 
Further imbalances in brain wave asymmetry between the left and right sides of 
the brain are also of interest. Depression and anxiety are two disorders that commonly 
occur with PTSD. Metzger et al. (2004) found that unique brain patterns could be used 
to identify depression and anxiety. Specifically, the Metzger et al. (2004) study indicated 
that Vietnam era female nurses had changes in right side frontal and parietal asymmetry 
when being assessed for PTSD symptomology. This study is potentially a foundational 
document in the exploration of brain function and the use of biomarkers in relationship 





The Metzger et al. (2004) study identified a potential gap for future study related 
to PTSD through analysis of increased/decreased parietal activity on the right side of a 
person’s brain. These findings support potential partial imbalances as one potential 
biomarker for PTSD. However, as with frontal cortical imbalances, this biomarker 
should not be considered as a single diagnostic indicator for PTSD. The proximity of the 
right parietal increase to the temporal lobe makes these findings interesting and 
potentially significant. Potential bleed over between the right parietal and the right 
temporal lobe imbalances with the left side of the brain are not common and could be 
detectable biomarkers of PTSD. 
 Relationships associated with asymmetry across multiple lobes when measured 
right to left versus individual lobes has shown that biomarkers might serve as 
differentiators of potential mental disorders. The Metzger et al. (2004) study indicated 
that frontal, temporal, and parietal activity can be evaluated through qEEG. This 
evaluation was used in an attempt to detect brain power and asymmetries across lobes. 
However, the research did not evaluate whether or not activity in one lobe might be 
affecting the asymmetries across additional lobes of the brain. For instance, the 
researchers did not find significant asymmetries across the frontal lobes of the subjects. 
This could be an indicator that the PTSD symptoms did not result in an imbalance 
between the right and left frontal lobe. However, there were detectable imbalances in 
brain power between the left and right parietal lobes of the subject’s brain.  
 The Metzger et al. (2004) study is significant because it reinforced and explored 





disorder alone has a distinct pattern, and depression co-occurring with PTSD has a 
different pattern all together. These patterns are potential indicators that can be used as 
biomarkers in the confirmation or rule-out of a PTSD diagnosis. Alternatively, these 
biomarkers could be used to confirm or rule out an independent major depressive 
disorder, anxiety disorder, and other mental disorders as identified in the DSM-5. This 
study is one of the foundational documents indicating that mental disorders can 
potentially be identified through the assessment and evaluation of brain activity. It is 
also one of the first studies that allows for precise differentiation between similar, 
comorbid, and cooccurring disorders. It also highlights that an independent disorder 
can have an impact on the way brain function is changed as a result of an activation 
(triggering) traumatic incident. 
Further support for the use of brain wave biomarkers is found in the areas related 
to limbic system activity. Anxiety is a common co-occurring disorder with PTSD. 
Identifying biomarkers in the brain based on potential asymmetries between the right 
and left side of the brain has been identified in past studies. Harper, Rasolkhani-
Kalhorn, and Drozd (2009) provided an exploration of trauma and the changes in the 
limbic system as related to hypervigilance and anxiety. The symptoms and brain effects 
can potentially be applied to the diagnosing of anxiety. The amygdala is the part of a 
person’s autonomic nervous system that triggers the fight, flight, or freeze response. The 
fight or flight response can present in a similar manner to the symptoms associated with 





(EMDR), the same findings might be used as a way to identify PTSD and anxiety 
biomarkers based on limbic system responses and reactions. 
A PTSD indicator would be the combination of changes in brain power visible in 
frontal and parietal lobes of the brain. Both changes would be considered abnormal 
activity in the brain. The potential indicators would be an increase on one side of the 
frontal cortex in alpha power (Lobo et al., 2015, Kemp et al, 2010). The authors further 
explain that increases in alpha power in this part of the brain have previously been 
associated with depression. Depression is a common disorder associated with PTSD 
(Kemp et al, 2010). The second part, identified by the authors, would be a significant 
increase in alpha power behind the person’s right ear. This area is commonly referred to 
as the T6 location on the brain. The T5 Area of a person’s brain is located behind the left 
ear. This is the area that would be the focus for comparison of brain wave activity across 
and between lobes of the brain. 
The Kemp et al, (2010) study is interesting because it is one of the first that 
focuses on hyper and hypo brain activity in relationship to depression and anxiety. The 
researchers hypothesized that anxiety could present with hyperactivity in the right 
parietal lobe and that depression might result in hypo activity in this region. Both of 
these results could be key indicators of an identifiable biomarker that could be used to 
confirm or dismiss a potential PTSD with anxious and/or depressive features. Overall, 
another potential brain wave activity and power biomarker that could be a clue to the 
potential organic changes that might occur in a traumatized brain. Another significant 





global increase across the frontal, parietal, and temporal lobes. This finding was not 
further explored in this study. However, it is another potential clue and area for further 
study by follow-on researchers. 
Alpha waves in particular are a point of key interest when associated with 
depression and PTSD (Kemp et al., 2010). As explained earlier, alpha wave asymmetry 
is a potential key biomarker for many disorders. The Kemp et al. (2010) study explores a 
potential relationship between PTSD and alpha asymmetries in the frontal and parietal 
lobes. It is important to note that the alpha wave activity may be within the expected 
range but still be imbalanced across the frontal and/or parietal lobes of the brain. This 
study focuses on these potential imbalances between the left and right sides of a 
subject’s brain, in the frontal and parietal lobes in particular. However, as with other 
studies, possible associations across brain lobes on the same side of the brain is an area 
of little research. For instance, is an imbalance from the left to the right side of the 
parietal lobe consistent with an imbalance in the frontal lobe? Hopefully, this 
dissertation will help answer this question.  
The findings of the Kemp et al. (2010) study indicate that imbalances existed in 
the study subjects. In this study, the brain waves of 44 patients with MDD, PTSD, and or 
a combination of the two disorders were compared to healthy/normal subjects. The 
study revealed imbalances across the frontal lobe in the subjects with MDD and PTSD. 
However, a different pattern was present when the subject had MDD alone or PTSD 
alone. The PTSD subjects presented a localized right frontal imbalance in brain wave 





left frontal lobe. These findings might be significant when attempting to determine and 
differentiate between related and unrelated trauma disorders. This differentiation could 
then result in biomarkers that are readily apparent when evaluated with a standard 
qEEG assessment of a person’s brain wave activity. In this case, alpha brain wave power 
imbalances across the frontal and parietal lobes are the significant areas revealed in this 
study. 
Preliminary research has been conducted regarding the presence of potential 
biomarkers as indicators of PTSD. Bandelow et al. (2016) identifies frontal lobe 
asymmetry as a potential biomarker for PTSD. However, this imbalance in alpha band 
power can also be indicators of other disorders. Depression is one disorder that also can 
also be identifed through the identification of increases in frontal alpha band activity on 
the left side and decreased activitiy on the right side. However, further research is need 
in order to determine if one area of the brain might be influencing the asymetries in 
other parts of the brain. The Bandelow et al. (2016) paper identifies potential 
independent biomarkers. However, identifying potential relationships between different 
lobes of the brain might help better understand the brain functioning process as related 
to PTSD. 
Comparison of left and right brain power activity has been an area of focus. 
However, identification of imbalances as potential biomarkers does not take in to 
account possible interactions between different and separate lobes of the brain. For 
instance, a paper published by Gordon, Palmer, and Cooper (2010) indicates that alpha 





the number of subjects presenting with this potential biomarker is significant and 
warrants further exploration. This finding supports the need for a second potential 
biomarker to support fontal alpha band imbalance as a possible indicator of PTSD or for 
a PTSD related depression. Additionally, potential interactions between lobes of the 
brain and not just across the same lobes is an area also needing further study. 
Quantitative electroencephalography (qEEG) provides a way to gather and 
analyze brain functioning and activity. Jokić-Begić and Begić (2003) conducted and 
presented the groundbreaking research related to qEEG and diagnosing mental 
disorders. As an example, qEEG can detect increases and decreases in brain wave 
activity such as beta and alpha waves. This ability potentially leads to the identification 
of areas in the brain that might not be functioning as found in neurotypical brains. 
These areas of abnormal activity can then be identified as biomarkers for mental health 
disorders such as PTSD. The Jokić-Begić and Begić (2003) study focused primarily on 
combat veterans with PTSD. However, these findings might also be extrapolated across 
all populations of people with a potential traumatic disorder. 
Identification of potential biomarkers is one solution for the accurate diagnosis of 
PTSD and other mental disorders. Todder et al. (2012) conducted research supporting 
the identification of biomarkers in specific areas of the brain. These biomarkers can 
then potentially be used to support an evidenced based diagnosis of PTSD using qEEG. 
The sample size (N = 20) is low but still provides an initial study into the potential 
functionality of biomarkers. A typical qEEG uses a process in which the subject 





closed, and 6 minutes of hyperventilation. However, in this study, the participants only 
spent 3 minutes with their eyes open for the qEEG assessment. This limitation is 
significant when the results might be compared to the larger population. Each phase of 
the qEEG is designed to gather and analyze different states of a person as they relate to 
brain activity. 
Identification of potential biomarkers is not the only potential benefit. Using the 
qEEG to guide treatment could be a logical next step. Wahbeh and Oken (2013) 
provides the efficacy of qEEG directed biofeedback/neurofeedback treatments for PTSD. 
In other contexts, the results of this research allow for constant monitoring of PTSD 
symptoms while the person is training. Typically, qEEG’s are conducted every 9 – 15 
months as a way to monitor progress. With this process, the biomarkers are highlighted 
and addressed as training progresses. Furthermore, Wahbeh and Oken (2013) identify 
some biomarkers related to heartrate and respirations that could be used in 
combination with future research. 
Additional biomarkers can further improve the ability for a practitioner to 
provide a solid diagnosis. A Jaworska et al. (2012) study provided a focus on alpha and 
beta waves provides consistency with previous studies and solidifies the foundations for 
future research. Power asymmetry, based on absolute frontal and parietal alpha, might 
be a finding that could provide another PTSD biomarker. Anger and hypervigilance are 






 The utilization of objective, evidenced-based diagnostic tools can help properly 
diagnose, treat, and support people suffering from trauma related mental disorders such 
as PTSD. Further research needs to continue as the world struggles with war, terrorism, 
and other violent acts that people inflict on others. The literature reviewed in Chapter 2 
provides the foundational evidence and highlights the need for an objective assessment 






Chapter 3: Research Method  
Introduction 
 The purpose of this study was to identify potential brain function biomarkers 
that can be used to assist in the detection or absence of PTSD-related symptoms and 
behaviors. This study was based on the theoretical framework and foundation of Carlson 
and Dalenberg (2000), who developed their theory on previous trauma-related research 
on the effects of traumatic events on people. The framework was based on the 
understanding that factors related to a trauma can result in cognitive, affective, 
behavioral, and physiological changes in a person. Traumatic events can result in 
observable changes to a person’s brain. The IRB approval number for this study is 05-
14-19-0491142 
 The study used a database of brain scans that were analyzed using current 
diagnosis criteria in the DSM-5. The goal was to detect imbalances in alpha brainwave 
activity in two separate lobes of the brain. These lobes were identified in previous 
research, which included? the distance from each other in the brain. Previous research 
focused on imbalances on the left and right side of each brain lobe. This study focused 
on the frontal and parietal lobes of a person’s brain.  
Research Design and Approach 
A quantitative archival research design was used to analyze data from qEEG 
scans and from a patient diagnosis of PTSD as a way to identify potential correlations 
between asymmetric brain wave activity in the frontal and parietal lobes of a subject’s 





associated with the ability to use quantifiable questions of an instrument-based 
database as a way to identify potential relationships between and across the designated 
variables (Creswell, 2009). The archival research design was selected based on the 
availability of data in an existing database as well as access to normative databases. 
These archives of patient information formed the basis of this study. Previous studies 
indicated that poor brain wave asymmetry across the frontal lobes could indicate 
depression and/or anxiety.  
However, studies on the additional effects of brain wave activity across other 
brain lobes or between brain lobes had not been conducted to the same level. Binary 
logistic regression was used to analyze potential relationships between the existence of 
diagnosed PTSD and each variable—symmetry and asymmetry of brainwaves—
independently and as a group (Creswell, 2009). Binary logistic regression also provided 
additional information about the potential interactions between each of the variables 
and across all factors. This is a potential finding when considering that the excess alpha 
in the prefrontal cortex might be a cause of excess alpha asymmetry in the parietal lobes, 
or vice versa.  
An existing qEEG database and research conducted on patient clinical records 
were the two sources of data for this study. The patient files included a confirmed 
diagnosis of PTSD or a disorder other than PTSD. The following variables were 
identified for use in this study: the dichotomous dependent variable was PTSD (yes or 





or no), and another dichotomous independent variable of excess alpha across the 
parietal lobes (yes or no) were analyzed using binary logistic regression.  
Setting and Sample 
Population 
The population for this study consisted of all clients and patients agreeing to 
participate in a qEEG brain function analysis and neuropsychological screening as part 
of their assessment process for mental health therapy at a large private medical practice 
on the west coast of the United States. There are over 400 clients and patients previously 
or currently being assessed at this facility. The practice provides a full range of mental 
health assessments and therapy to people aged 4–90. 
Participants 
Participants for this study were selected using a two-stage cluster sampling 
procedure. The first stage is that all records of patients who agreed to participate in the 
analysis and screening of study were extracted and divided into two groups. The first 
group consists of all patients diagnosed with PTSD. The second group consists of clients 
and patients that are not diagnosed with PTSD, or other mental health disorders. 
The second stage of the sampling procedure is a random selection of the clients 
and patients in each group. A random selection of 108 clients and patients, 54 having a 
diagnosis of PTSD and 54 without, were selected for inclusion into the study. The 
inclusion criterion was: 
1. Clients and patients between the ages of 18 and 90 years. 





1. A diagnosis of mental health disorder other than PTSD. 
2. PTSD clients and patients having co-occurring mental health diagnoses. This 
includes subjects with two or more mental health diagnosis or substance 
abuse disorder. 
Records were analyzed in a way that maintain participant anonymity. The data 
extracted did not contain identifying information. Each participant was given a random 
identification number, which was assigned by the institution. The list linking the patient 
with the identification number remained in a locked file with the business manager. In 
case of any issues with the extracted data, the researcher consulted with the business 
manager and the business manager would assign someone at the institution to 
investigate the issue. The result(s) were provided to the researcher maintaining the 
anonymity of the study participant. 
The study was anonymous; therefore, the name and any identifying information 
of the client/patient was unknown to the researcher and the findings were reported only 
in the aggregate. Each participant had a random number assigned in order to mask the 
identity of the person.  
Variables, Measurements, and Instruments 
 Two independent and one dependent variable were used for this proposed study. 
This section describes each independent variable and dependent variable. Specifically, it 






The following demographic variables were extracted from the records of the 
participants. These variables were used to summarize, describe, and compare the 
samples. In addition, the demographic variables were used to compare the group 
diagnosed with PTSD with the group that does not have an existing diagnosis of PTSD. 
The following variables were extracted from the participant’s records: 
1. Age 
2. Gender 
3. Other non-mental health illnesses 
4. Reason for the qEEG 
Independent Variables 
The independent variables in this study was the comparison of alpha brain waves 
between the left and right frontal lobes and between the left and right parietal lobes to 
determine if the speed of alpha brainwaves is synchronous or asynchronous. 
Alpha wave activity was assessed through an evaluation of the qEEG in 
participant records. The Neuroguide Normative Database was used to evaluate 
participant’s qEEG record into cycles per second for the alpha waves in both 
hemispheres of the frontal and parietal lobes. The neuroguide program produces a table 
that presents the amplitude and cycles per second of brain wave activity in specific 
locations on a person’s brain. The numbers were arranged in a left and right manner 
and symmetry and asymmetry were easily observable, based on the numbers in the 





Excel. The speed of the right frontal lobe (F3) was compared to the speed of the left 
frontal lobe (F4). This difference was calculated in Excel subtracting the F3 from F4. If 
the absolute value of the difference between F3 and F4 was within 1 cycle per second, 
the frontal lobes were considered synchronous. If the difference between F3 and F4 
greater than 1 cycle per second, the frontal lobes were considered asynchronous.  
Similarly, the parietal lobes were evaluated for synchronous and asynchronous 
alpha waves. Using the neuroguide normative database, the speed of the right parietal 
lobe (P3) was compare to the left parietal lobe (P4). 
The following are the independent variables 
1. Synchronous frontal lobe: yes/no 
2. Synchronous parietal lobe: yes/no 
Dependent Variable 
The dependent variable was the diagnosis of PTSD, which is measured as yes or 
no. A diagnosis of PTSD was assessed using the DSM-5 criteria. A person meeting or 
exceeding the symptoms and behaviors defined by the DSM-5 criteria for PTSD 
diagnosis was considered having PTSD. All persons not meeting the PTSD criteria 
defined by DSM-5 was considered a “no” in the study. The subject that does not meet 
criteria could have a different mental health diagnosis or no diagnosis as identified by 
ICD-10 identifiers. 
The patient was evaluated using the PTSD Diagnosis Scale. This is a 30-item 





Walker (2003) provided the following description of the neuroguide normative 
database: 
The Neuroguide normative database in versions 1.0 to 2 4 6 included a total of 625 
carefully screened individual subjects ranging m age from 2 months to S2 years. 
NO 2.5.1 (6 12 200S) involved the addition of 53 adult subjects ranging in age from 
18 3 years to 72 6 years resulting in a normative database of 678 subjects. The 
inclusion exclusion criteria, demographics, neuropsychological tests, Gaussian 
distribution tests and cross validation tests are described in several peer reviewed 
publications (Thatcher et al, 1953; 1987, 2003). Two year means were computed 
using a sliding average with 6 month overlap of subjects This produced a stable 
and higher age resolution normative database with a total of 21 different age 
groups. The individuals used to create the normative database met specific clinical 
standards of no history of neurological disorders, no history of behavioral 
disorders, performed at grade level in school, etc. Most of the subjects in the 
normative database were given extensive neuropsychological tests. (p. 7) 
The PTSD Diagnosis Scale has demonstrated high internal consistency (alpha = 
.95) and test-retest reliability (r = .90). In addition, it showed good divergent validity 
with the Beck Depression Score (Foa, 2016). 
Power Analysis 
A power analysis was conducted to determine the sample size that would be 





medium effect size of 0.30. The power analysis was conducted using the the G*Power 
3.1 online calculator. A total sample size of 108 participants is needed to test each of the 
null hypotheses. 
Design 
To examine the relationship between PTSD and alpha waves, a non-equivalent 
control group design was used (Cook & Campbell, 1968). In this design, participants 
were grouped according to their diagnosis of PTSD. Thus, random assignment to group 
did not occur. 
In the non-equivalent control group design clients in Group A had an existing 
diagnosis of PTSD. The second group, Group B is the control group and did not have a 
diagnosis of PTSD. Clients in both groups were evaluated using the qEEG. The results of 
the qEEG were used to evaluate the correlation between PTSD and alpha bran wave 
activity. 
Procedure 
A total sample of 108 randomly selected records were identified at the private 
practice to be extracted and used in this study, 54 diagnosed with PTSD and 54 not 
diagnosed with PTSD. Because there has been no evidence to support brain waves 
difference based on demographic variables, a random sample was selected. Computer 
generated random number assignment were used to select patient records. The 
following information was extracted from the patient’s record: gender, age, qEEG, PTSD 





further evaluated using the Neuroguide Normative Database to assess synchronous and 
asynchronous alpha activity in the parietal and frontal lobes. 
Data Analysis Plan 
Descriptive statistics were assessed for the demographic, independent, and 
dependent variables. Categorical variables were summarized using frequencies and 
percent. Continuous variables were summarized using means and standard deviations. 
To assess comparability of groups, the demographic variables, reasons for qEEG and 
other non-mental health illnesses were compared. A chi-square was used to assess 
group differences for categorical data. T-test was used to assess group differences for 
continuous variables. 
The dependent variable was diagnosis of PTSD (yes or no). The independent 
variable was frequency and/or power symmetry (yes or no) across frontal lobe. A logistic 
regression was used to test whether PTSD can be predicted from knowing extent of 
symmetry across the frontal lobe. From the logistic regression, an odds ratio was 
estimated. To examine the model fit, Hosmer and Lemeshow test was used. A p-value 
greater than 0.05 indicates the data fit the model. To assess the relationship between 
PTSD and frontal lobe symmetry, the variance accounted for were used. In addition, the 
overall accuracy of predictions was examined. 
To assess the contribution of detectable frequency and/or power symmetry of 
alpha waves in the parietal lobe, a logistic regression was used to predict PTSD from the 
extent of symmetry of the alpha brain activity across the parietal lobes (yes or no). From 





and Lemeshow test was used. A p-value greater 0.05 than indicates the data fit the 
model and the model is reliably significant. To assess the relationship between PTSD 
and parietal lobe symmetry, the variance accounted for was used. In addition, the 
overall accuracy of predictions was examined. SPSS version 22 was used to conduct the 
analysis. 
Ethical Considerations 
All data for this study is archival data collected as part of the typical assessment 
process at this private practice. Information was masked and all identifying information 
was removed prior to placement in the study data collection sheets. Data will only be 
kept on a computer system with two levels of password protection. Access to study 
related information and files was restricted to the practice site director, dissertation 
committee, and the researcher. All files related to this study were maintained in a secure 
archive in accordance with current APA guidelines after study completion and then 
destroyed. The site director has approved the process of masking the data and use in 
this dissertation. 
Threats to Validity 
The primary instrument for this study is the qEEG brain function scan. It has 
been shown to be both reliable and valid for purposes of data collection (brain wave 
patterns) and preparation for analysis. The instruments used to diagnose PTSD have 
been used for many years with well-established validity and reliability. Each screening 
tool and neuropsychological instrument has been applied and evaluated by a licensed 





historical information regarding validity and reliability of standard screening tools and 
neuropsychological instruments is not explored in this study. However, the external and 
internal validity associated with qEEG were presented.  
Threats to External Validity 
Generalization is significant in that the results should be applicable to the larger 
population. In other words, the larger the population would better represent the 
population in general. However, this study is limited to the qEEGs from one practice 
that meet the inclusion criteria.  
In addition, there is a potential interaction between the reason a person is 
referred to get a qEEG and diagnosis of PTSD. Some clients may have PTSD and are not 
diagnosed with PTSD. Many people pick this practice because a qEEG may help identify 
specific mental health disorders. Mental and emotional trauma is a specialty at this 
clinic and could have a disproportionate number of clients from this population.  
Threats to Internal Validity 
Thatcher (2010) indicates that the strengths of the quantitative aspect of an EEG 
differentiates the qEEG and a typical EEG. High levels of test-retest and split half results 
make quantitative evaluation stronger than traditional EEG readings. A qEEG shows 
strong content validity and has correlations to other traditional assessment instruments 
such as MRI, SPECT, and neuropsychological testing (Thatcher, 2010). 
Internal validity will potentially be stronger as the database of qEEG brain scan 
grows. The current database exceeds the G*Power estimate and should be significantly 





contains qEEG results from clients assessed as part of the normal clinical intake and 
reassessment process. Threats to validity of the database could include improper 
placement of leads and poor coherence related to the connection between client and the 
equipment. This threat has been countered by each of these items being inspected by at 
least one other trained observer prior to starting a qEEG brain wave assessment. 
Summary 
Chapter 3 presents the methodology used to evaluate the study research 
questions and understand the variables as identified in Chapter 1. The literature review 
emphasized the importance of a strong evidence base when evaluating the potential 
presence of abnormal brain wave activity. The intention to use binary logistics 
regression should allow for an increased understanding of Alpha wave activity within 
specific lobes of the brain and then between lobes of the brain. Focus of the study is 








Chapter 4: Results 
The intent of the study was to determine if certain brain wave imbalances 
represent and match the symptomology experienced by people with PTSD. The ability to 
extrapolate this information from the front to the back of the brain could increase the 
strength of a biomarker. This would differentiate qEEG from traditional 
neuropsychological assessment in that a reading of brain scan could potentially replace 
subjective assessment processes. 
This chapter focuses on the analysis of, and results from, the data on brainwave 
asymmetry in the frontal and parietal lobes in diagnosing PTSD. It consists of six 
sections. The first section summarizes the procedures used to analyze the data. The 
second section summarizes the procedure used to classify a patient as having PTSD or 
not. The third describes the sample that was used in the analysis. The fourth examines 
Research Question 1, which considers the impact of frontal lobe asymmetry on PTSD. 
The fifth examines Research Question 2, which assesses the impact of parietal lobe 
asymmetry on PTSD. The sixth section summarizes the diagnostic screening utility of 
using asymmetrical brainwaves to detect PTSD. 
Summary of Procedures 
The individuals used in this study were clients of a private practice who had been 
referred to the practice for a qEEG procedure; 108 individuals were included in the 
sample. Each client in the study had a been evaluated for PTSD using the criteria in the 
DSM-5. In addition, the qEEG had been evaluated for brainwave asymmetry of the 





included gender, age and PTSD diagnosis (yes or no). To assess the use of the frontal 
lobe asymmetry, a logistic regression was conducted in detecting PTSD. To assess the 
use of the parietal lobe asymmetry, an initial logistic regression was conducted to detect 
PTSD.  
Summary of PTSD Diagnosis 
The clients in this study were classified as having PTSD or not having PTSD 
through an assessment using the DSM-5 criteria. A person meeting or exceeding the 
symptoms and behaviors defined by the DSM-5 criteria for a PTSD diagnosis was 
considered to have PTSD. All persons not meeting the PTSD criteria defined by DSM-5 
was considered a no in the study. Any subject who did not meet criteria could have a 
different mental health diagnosis or no diagnosis, as identified by ICD-10 identifiers. 
Sample 
A total of 108 clients from a private practice were included in this study (see 
Table 1). Half of the clients had a diagnosis of PTSD using the criteria in the DSM-5; the 
other half were not diagnosed with PTSD. Approximately 53% of the clients identified as 
female. In the sample, there was one person who was born male and identified as 
female, and one person who was born female and identified as male. Approximately 
42% of the clients were between the ages of 31 and 50 years old; 39.8% were less than 
30 years old and approximately 18% were older than 50 years old.  
With respect to asymmetry, approximately 52% had frontal lobe brainwave 
asymmetry and 59% had parietal lobe brainwave asymmetry. In addition, 57% had a 







Table 1  
Sample Demographics 




    No 





   Female 




Frontal lobe asymmetry 56 (51.9) 
Parietal lobe asymmetry 64 (59.3) 
Non-PTSD diagnosis 63 (57.4) 
Age (in years) 
    <30  
   31 to 50 






The Impact of Frontal Lobe Asymmetry on PTSD 
Research Question 1: Does a sample of tested adults diagnosed with PTSD have 
detectible alpha brain wave asymmetries across the frontal lobe? 
1. H0: There is no relationship between detectable alpha brain wave 
asymmetries across the frontal lobe and PTSD. 
2. H1: There is a relationship between detectable alpha brain wave asymmetries 
across the frontal lobe and PTSD. 
Table 4.2 provides the regression coefficients derived from the logistic regression 





PTSD. The regression coefficient for frontal lobe asymmetry is -1.60 with a standard 
error of 0.40. Indicating a negative association between frontal lobe asymmetry and 
PTSD. In this univariate model, the model was significant (chi-square=7.35, df=1, 
p=0.007). However, the logistic regression model did not fit the data, thus the results of 
p<0.0001 were not reliable (Hosmer & Lemeshow). From the logistic regression model, 
63% of the clients diagnosed with PTSD were correctly identified and between 7% and 
8% of the variance in PTSD was accounted for by frontal lobe asymmetry (see table 4.3). 
There is not enough data to reject the null hypothesis. 
Table 2  




 (s.e.) 2 
 
p-value 




Overall Model  7.35 .007 6.6% 8.8% 
Frontal lobe asymmetry -1.60 (.40)    












Table 3  
Correct identification of PTSD: frontal lobe logistic regression 




True Classification No Yes  
PTSD No 35 19 64.8% 
 Yes 21 33 61.1% 
Overall Percentage    63% 
 
The Impact of Parietal Lobe Asymmetry on PTSD 
Research Question 2: Does a sample of tested adults diagnosed with PTSD have 
detectible alpha brain wave asymmetries across the parietal lobe? 
1. H0: There is no relationship between detectable alpha brain wave 
asymmetries across the parietal lobe and PTSD. 
2. H1: There is a relationship between detectable alpha brain wave asymmetries 
across the parietal lobe and PTSD. 
Table 4.4 provides the regression coefficients derived from the logistic regression 
used to assess the impact of parietal lobe asymmetry in correctly identifying patients 
with PTSD. The regression coefficient for parietal lobe asymmetry is 0.78 with a 
standard error of 0.40. Indicating a positive association between parietal lobe 
asymmetry and PTSD. In this model, the model was significant (chi-square=3.86, df=1, 





nine percent of the clients diagnosed with PTSD were correctly identified and between 
3.5% and 4.9% of the variance in PTSD was accounted for by parietal lobe asymmetry 
(see table 4.5). The percent of non-PTSD diagnosed clients were correctly identified was 
50%, suggesting a poor performance of the model correctly classifying PTSD. 
Table 4  













Overall Model  3.86 .05 3.5% 4.9% 
Parietal lobe 
asymmetry 
.78 (.40)     
Constant -.46 (.31)     
 
Table 5  
Correct identification of PTSD: parietal lobe 




True Classification No Yes  
PTSD No 27 27 50% 
 Yes 17 37 68.6% 






Summary: Evaluation of Diagnostic Tests 
Brain wave analysis, as a potential diagnostic test, might be a way to help 
determine the appropriateness of qEEG results of frontal lobe and parietal lobe brain 
waves to diagnose PTSD. In day-to-day clinical practice, it would potentially be more 
efficient to be able to rule out PTSD or rule in PTSD using an objective measure as 
opposed to the gold standard of administering the criteria of the DSM-5. Table 4.6 
presents the comparison of the sensitivity, specificity, predicted values and the 
likelihood ratio.  
Table 6  




Model 2  
Frontal lobe 
Sensitivity 68.50% 61.10% 
Specificity 50% 64.80% 
PV+ 57.80% 63.50% 
PV- 61.40% 62.50% 
LR+ 1.37 1.73 
LR- 0.63 0.6 
  
 Examining the model with the independent variable parietal lobe, the 
presence of asymmetry in the parietal lobe is inappropriate. As seen in Table 4.6, both 
the sensitivity and specificity are low (68.5% and 50%, respectively). A sensitivity of 
68.5% indicates that approximately 31.5% of the sample was classified as a false 





misclassified as a false negative. High value of sensitivity and specificity suggest this 
model is not appropriate to correctly classify PTSD. Confirming the information 
sensitivity and specificity provide, the positive likelihood ratio (LR+) is 1.37 indicating a 
small power to rule in PTSD. The negative likelihood ratio (LR-) .6 indicates a small 
power to rule out PTSD. 
Similarly, the second model with the frontal lobe as the independent variable 
does not correctly classify PTSD clients. A sensitivity of 61% and specificity of 64.8% 
suggests a high proportion of false positives and false negatives, respectively. 
Confirming the information sensitivity and specificity provide, the positive likelihood 
ratio (LR+) is 1.73 indicating a small ability to rule in PTSD. The negative likelihood 






Chapter 5: Conclusions and Recommendations  
The purpose of the study was to determine if certain brain wave imbalances 
represent and match the symptomology experienced by people with PTSD. This chapter 
presents the conclusions and recommendations of this study. It consists of four sections. 
The first section summarizes the results of the study. The second section identifies the 
conclusions drawn from the study. The third section discusses the limitations of the 
study, and the last section suggests future directions. 
Summary of the Results 
Research Question 1: Does a sample of tested adults diagnosed with PTSD have 
detectable alpha brain wave asymmetries across the frontal lobe? 
1. H0: There is no relationship between detectable alpha brain wave 
asymmetries across the frontal lobe and PTSD. 
2. H1: There is a relationship between detectable alpha brain wave asymmetries 
across the frontal lobe and PTSD. 
The results of the logistic regression suggest: 
a. There is no relationship between frontal lobe asymmetry and PTSD. 
b. Frontal lobe asymmetry does not classify PTSD well. Frontal lobe asymmetry 
should not be used alone to diagnose PTSD. 
Research Question 2: Does a sample of adults diagnosed with PTSD have 
detectible detectable alpha brain wave asymmetries across the parietal lobes? 
1. H0: There is no relationship between detectable alpha brain wave 





2. H1: There is a relationship between detectable alpha brain wave asymmetries 
across the parietal lobe and PTSD. 
The results of the logistic regression suggest: 
a. There is no relationship between parietal lobe asymmetry and PTSD. 
b. Parietal lobe asymmetry does not classify PTSD, it provides an unreliable 
classification of PTSD. Parietal lobe asymmetry should not be used alone to 
diagnose PTSD. 
Discussion 
PTSD is a topic of particular relevance, not only for military personnel and 
veterans, but also police officers, firefighters, emergency medical technicians, and other 
first responders who are among those exposed to traumatic events in the course of their 
duties. Typically, PTSD is diagnosed using the criteria in the DSM-5, using self-report 
measures. Instruments based on DSM-5 have been assessed as reliable and valid in 
diagnosing PTSD. However, a by-product of self-administered inventories is that PTSD 
symptoms can be coached and rehearsed before a person visits a mental health therapist 
(Potik, Feldinger, & Schreiber, 2012). In addition, self-report measures require patients 
to have sufficient insight into the extent and impact of their symptoms and to provide 
accurate information to clinicians and researchers. A number of factors can influence 
self-report, including the desire to appear more or less symptomatic than one is in 
reality (Bryant et al., 2018). This can result in misdiagnosing patients. 
In contrast, the use of biomarkers, such as brain wave asymmetry in the frontal 





biomarkers would be to obtain objective evidence of the presence or absence of PTSD. In 
addition, asymmetry would be used to confirm the diagnosis of PTSD, even when the 
person is asymptomatic. Ideally, the use of asymmetry in the frontal and parietal lobes 
would be accurate, providing high sensitivity and specificity. Unfortunately, diagnostic 
screening is not perfect, and screening should have a low likelihood of errors, such as 
false positives and false negatives. 
This study evaluated asymmetries in brainwaves from qEEGs as a way to 
potentially provide evidence in supporting asymmetry in brain waves in the frontal 
and/or parietal lobes as objective diagnostic tools for PTSD. The screening for PTSD can 
serve multiple purposes. The first is to identify individuals at high risk for developing 
PTSD, but who have not manifested its symptoms. Individuals who are at a high risk for 
future development of PTSD can be treated before symptoms appear. In addition, an 
offered support mechanism to address symptoms could provide therapeutic value. 
Second, in addition to risk assessment, screening provides an opportunity for 
early detection or identification of PTSD cases in individuals who are experiencing some 
PTSD symptoms but do not meet full criteria. Screening also provides the ability to 
discover previously unidentified cases of more chronic and severe PTSD. These 
individuals would be candidates for currently available evidence-based interventions. In 
addition, being able to identify such cases of PTSD would not only increase the 
incidence and prevalence, it also would facilitate the research efforts to better 
understand PTSD and develop additional treatment options. Finally, being able to 





and other mental health issues, preventing unnecessary administration of depression 
medications and management of serious side effects, potentially improving the quality 
of life of PTSD patients (Jackson et al., 2018). 
To be an effective objective measure of PTSD, the screening classification of 
frontal and parietal lobe asymmetry did not separately provide support for accurate 
diagnosis of PTSD. Using either parietal lobe asymmetry or frontal lobe asymmetry 
produced results that were unreliable. These results suggest that asymmetry in the 
frontal and parietal lobes should not be used as the primary screening method for PTSD. 
However, the model can be used in a supporting role, as a brief screening tool, to trigger 
the traditional processes to diagnosis of PTSD to rule PTSD out as a potential mental 
health condition and/or disorder. While Thatcher, (2010) has indicated 
neuropsychological testing has promise in the objective correct classification of PTSD, 
these results indicate that neuropsychological testing might be enhanced through 
comparisons to a patient’s brain wave activity. 
The major implications of the hypothesis not being supported is that brain waves 
in the frontal and parietal lobes might not be sufficient to diagnose PTSD. The addition 
of additional biomarkers from additional brain lobes, such as temporal lobe changes, 
might add additional diagnostic credibility. Another potential implication is the 
continued use of assessments that might not provide the diagnostic fidelity needed for a 
disorder as complex as PTSD. These implications potentially support future research 
efforts regarding brainwave activity and the identification of biomarkers related to 





Limitations and Delimitations 
The primary limitation to this study is that the sample consisted of individuals 
who used a single private practice. This study did not take into consideration how the 
clientele of this practice differs from other medical practices. There were two 
delimitations in this study. First, the study was conducted in one geographic location. 
Therefore, the results may not generalize to other geographic locations. Second, the 
research was conducted at a private medical office and therefore the assumption that the 
results would be the same at other medical practices should be avoided. Despite the 
limitations of this study, examining the use of asymmetrical frontal and parietal lobe 
brainwaves is important insights in the area of diagnostic testing of PTSD. 
 
Conclusion 
This study explored the presence of alpha asymmetries in the frontal lobe and 
alpha wave imbalances between the right and left parietal lobes as potential biomarkers 
in identifying (or ruling out potential) PTSD. However, the relationship between certain 
brain function biomarkers and PTSD did not yield significant results that would indicate 
the utility of the biomarkers as a primary diagnostic tool. Thus, the results do not 
provide an evidence-based process to support the diagnosis of PTSD. 
The primary purpose of this study was to correctly diagnose PTSD using 
biomarkers based on asymmetry of alpha brain waves across the frontal and parietal 
lobes. The results of this study do not provide support for the conclusion below. These 





across the parietal lobe and asymmetry of alpha brain waves across the frontal lobes 
separately without using additional demographic variables or the interaction of the 
asymmetrical alpha brain waves between the parietal and frontal lobes. 
1. Asymmetry across the frontal lobe is not appropriate for diagnosing PTSD. 
This finding is inconsistent with Bandelow et al. (2016), who identified frontal 
lobe asymmetry as a potential biomarker for PTSD. Bandelow et al. (2016), 
also found that the increase in asymmetry in the frontal lobe can also be 
indicators of depression. However, in this study people with depression were 
not included in the study.  
2. The findings were also inconsistent with Metzger et al. (2004) in identifying 
unique brain patterns in identifying depression and anxiety in Vietnam era 
female nurses. Metzger et al, found the nurse had changes in right side frontal 
and parietal asymmetry when being assessed for PTSD symptomology. While 
this study was foundational for the exploration of brain functions and the use 
of biomarkers in relationship to potential mental disorders, Metzger et al. 
(2004) did not isolate nurses with PTSD from depression and anxiety. In 
addition, Metzger et al. (2004) focused on the right side of the parietal lobe 
and found biomarkers can be used in the confirmation or rule out of PTSD 
diagnosis. The current study supports the use of biomarkers in ruling out 
PTSD. The negative likelihood ratio indicates asymmetry across the frontal 





3. Kemp et al. (2010) found that PTSD patients showed a global increase across 
the frontal and parietal lobes. In particular, Kemp et al. (2010) found PTSD 
subjects presented a localized right frontal imbalance in brain wave activity. 
This study is inconsistent with Kemp et al. (2010) findings, there were no 
statistically significant increase in asymmetric alpha brain waves in the 
frontal or parietal lobes. 
4. Jokić-Begić and Begić (2003) studied combat veterans with PTSD and found 
abnormal brain activity identified as biomarkers for mental health. Jokić-
Begić and Begić (2003) suggested the findings might be extrapolated across 
all populations of people with PTSD. The findings of this study are 
inconsistent with extrapolating abnormal brain activity to diagnosis PTSD. 
Biomarkers related to brain wave activity had been informally identified by qEEG 
practitioners as a way to potentially identify mental health disorders. The potential 
PTSD biomarker, parietal lobe asymmetry, has been a way to highlight clients that have 
experienced trauma. The desire to link this potential biomarker to the known anxiety 
and depression biomarkers was anticipated to help solidify a more definitive 
identification of PTSD related biomarkers. This study has provided additional 
information related to potential PTSD related biomarkers. However, these potential 
biomarkers will need to be used with caution and only as a way to identify patients for 





Future Research Recommendations 
Future research considerations could include additional brain biomarkers. The 
addition of potential brain patterns might provide increased accuracy when brain wave 
asymmetries are detected. Including data gathered from other systems might also 
provide better results. For instance, heart rate and/or breathing rate could be an 
indicator of an increase in distress. 
Ultimately, the technology and future research should progress to the point that 
biomarkers can be potential indicators related to mental health disorders. The 
important message from this dissertation is that biomarkers may exist, but just not with 
the level of reliability that is attainable at this point. Adding additional factors and 
improved equipment could be ways in which the reliability of the date could be 
improved. It is important to note that these data might indicate a potential for a 
screening tool for PTSD based biomarkers. However, at this point, traditional methods 
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